标普和纳斯达克内在价值 联系我们

STRATA Skin Sciences, Inc. SSKN OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
29/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

STRATA Skin Sciences, Inc. (SSKN) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 28/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
29/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
100/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
0/100
Debt-to-Equity & liquidity
→ Health
~
护城河
46/100
→ Income
成长
15/100
→ Income
收入
10/100
→ Income

估值概览 — SSKN

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.18
EV/EBITDA0.0
每股数据
EPS (TTM)$-1.35
每股账面价值$0.00
每股营收$0.66
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2016 $-14.40 $31.76M $-3.34M -10.5%
2017 $-32.60 $31.45M $-21.51M -68.4%
2018 $-1.48 $29.86M $-4.03M -13.5%
2019 $-1.18 $31.59M $-3.79M -12%
2020 $-1.31 $23.09M $-4.41M -19.1%
2021 $-0.79 $29.98M $-2.71M -9%
2022 $-1.60 $36.16M $-5.55M -15.3%
2023 $-3.10 $33.36M $-10.83M -32.5%
2024 $-2.65 $33.56M $-10.09M -30.1%
2025 $-1.35 $30.7M $-6.26M -20.4%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言